Memantine for the treatment of dementia

This publication has 13 references indexed in Scilit:

• Resource Utilisation and Cost Analysis of Memantine in Patients with Moderate to Severe Alzheimer??s Disease
  PharmacoEconomics, 2003
• A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500)
  International Clinical Psychopharmacology, 2002
• Efficacy and Safety of Memantine in Patients With Mild to Moderate Vascular Dementia
  Stroke, 2002
• Neuro-radiological findings and the magnitude of cognitive benefit by memantine treatment. A subgroup analysis of two placebo-controlled clinical trials in vascular dementia
  European Neuropsychopharmacology, 2000
• Detailed assessment of cognition and activities of daily living in moderate to severe Alzheimer's disease
  Neurobiology of Aging, 2000
• The Severe Impairment Battery
  Alzheimer Disease & Associated Disorders, 1997
• An Inventory to Assess Activities of Daily Living for Clinical Trials in Alzheimerʼs Disease
  Alzheimer Disease & Associated Disorders, 1997
• Functional Assessment Staging (FAST) in Alzheimer’s Disease: Reliability, Validity, and Ordinality
  International Psychogeriatrics, 1992
• Treatment of Impaired Cerebral Function in Psychogeriatric Patients with Memantine - Results of a Phase II Double-Blind Study
  Pharmacopsychiatry, 1988
• “Mini-mental state”
  Journal of Psychiatric Research, 1975